Correlation Between AbbVie and Novartis
Can any of the company-specific risk be diversified away by investing in both AbbVie and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbbVie and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AbbVie Inc and Novartis AG ADR, you can compare the effects of market volatilities on AbbVie and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbbVie with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbbVie and Novartis.
Diversification Opportunities for AbbVie and Novartis
Poor diversification
The 3 months correlation between AbbVie and Novartis is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding AbbVie Inc and Novartis AG ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG ADR and AbbVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbbVie Inc are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG ADR has no effect on the direction of AbbVie i.e., AbbVie and Novartis go up and down completely randomly.
Pair Corralation between AbbVie and Novartis
Given the investment horizon of 90 days AbbVie Inc is expected to under-perform the Novartis. In addition to that, AbbVie is 3.81 times more volatile than Novartis AG ADR. It trades about -0.15 of its total potential returns per unit of risk. Novartis AG ADR is currently generating about -0.19 per unit of volatility. If you would invest 10,935 in Novartis AG ADR on September 2, 2024 and sell it today you would lose (358.00) from holding Novartis AG ADR or give up 3.27% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
AbbVie Inc vs. Novartis AG ADR
Performance |
Timeline |
AbbVie Inc |
Novartis AG ADR |
AbbVie and Novartis Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AbbVie and Novartis
The main advantage of trading using opposite AbbVie and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbbVie position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.AbbVie vs. Tff Pharmaceuticals | AbbVie vs. Eliem Therapeutics | AbbVie vs. Inhibrx | AbbVie vs. Enliven Therapeutics |
Novartis vs. AstraZeneca PLC ADR | Novartis vs. GlaxoSmithKline PLC ADR | Novartis vs. Roche Holding Ltd | Novartis vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Money Managers Screen money managers from public funds and ETFs managed around the world |